المؤلفون: Herrera, F., Cuervo, Guillermo, Carratalà, J., Novo, A., Manzur, A., Tilley, R., Yáñez, L., Del Pozo, J.L., Peghin, M., Araos, R., Hemmatti, P., Gomes, M.Z.R., Marin, J.I., Márquez-Gómez, I., Calik, S., Sipahi, O.R., Kanj, S.S., Montero, M., Maestro-De La Calle, G., Morales, I., Kern, W.V., Isler, B., García, E., Brunel, A.-S., Paz Morales, H., Drgona, L., Gasch, O., Tubau, Fe, Escrihuela-Vidal, Francesc, Martín-Dávila, P., Aguado, José María, Horcajada, Juan Pablo, Mikulska, M., Tebé, Cristian, Arias, Marisol Rodríguez, Aguilar-Company, Juan, Larrosa, Nieves, Cardozo, Celia, Garcia-Vidal, Carolina, Karim-Yaqub, Ibrahim, Greco, Raffaella, Montejo, M., AKOVA, MURAT, Oltolini, C., Abdala, E., Puerta-Alcalde, P., Ruiz-Camps, I., Mussetti, A., Pallarès, N., Laporte-Amargós, J., Albasanz-Puig, A., Gudiol, C., Cichero, Paola, Ayaz, Caglayan Merve, Céspedes, Roberto, López-Soria, Leire, Magnasco, Laura, Fortún, Jesús, Torres, Diego, Boté, Anna, Espasa, Mateu, Montaguti, Mia Hold, Bochud, Pierre-Yves, Manuel, Oriol, Carrasco, Salvador Tabares, López, Josefina Serrano, Bertz, Hartmut, Rieg, Siegbert, De Cueto, Marina, Rodríguez-Baño, Jesús, Lizasoain, Manuel, Sangro Del Alcázar, Paloma, Castaldo, Nadia, Bassetti, Matteo, Munita, Jose, Maschmeyer, Georg, Tonhá, João Pedro Silva, Aparecida Da Silva Machado, Amanda, Correa, Lina Clemencia, Palop, Begoña, Nazli-Zeka, Arzu, Uyan-Onal, Ayse, Jabbour, Jean-Francois, El Zein, Saeed

المساهمون: Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España), Red Española de Investigación en Patología Infecciosa, European Commission, Promex Stiftung Fur Die Forschung, Gilead Sciences, MSD, Astellas Pharma, Novartis, Pfizer, Ege Üniversitesi

المصدر: Antimicrob Agents Chemother
Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: Male, Carbapenem, Bacteremia, predictive model, 0302 clinical medicine, Risk Factors, Drug Resistance, Multiple, Bacterial, Neoplasms, Pharmacology (medical), 030212 general & internal medicine, Antibiotic prophylaxis, Cancer, 0303 health sciences, Middle Aged, Antibiotic coverage, Anti-Bacterial Agents, Infectious Diseases, Treatment Outcome, Pseudomonas aeruginosa, Female, medicine.drug, medicine.medical_specialty, Neutropenia, Antibiotic sensitivity, bloodstream infection, Microbial Sensitivity Tests, Tazobactam, Models, Biological, Epidemiology and Surveillance, 03 medical and health sciences, Internal medicine, medicine, cancer, Humans, Pseudomonas Infections, multidrug resistant, Pseudomonas aeruginosa, bacteremia, bloodstream infection, neutropenia, cancer, risk factors, predictive model, Retrospective Studies, Pharmacology, 030306 microbiology, business.industry, multidrug resistant, Retrospective cohort study, Odds ratio, Multidrug resistant, Risk factors, ROC Curve, Predictive model, Bloodstream infections, business, Bloodstream infection, Piperacillin

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24063e2550e52d64508529f23f8eb2ca
https://avesis.deu.edu.tr/publication/details/e1b28889-d8e7-4d3e-8ae9-2109703791d9/oai